Showing results (41-50 of 101) with videos related to

Sort By:
Pageof 11
Anaerobe|October 7, 2018
Atopobium vaginae intrapartum bacteremia: A case report with a literature reviewNicolas Dauby, Delphine Martiny, Laurent Busson, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|October 11, 2020
A score combining early detection of cytokines accurately predicts COVID-19 severity and intensive care unit transferCarole Nagant, Fanny Ponthieux, Julie Smet, et al.
Acta Clinica Belgica|September 14, 2021
Clinical features of Legionnaires' disease at three Belgian university hospitals, a retrospective studyMarco Moretti, Sabine D Allard, Nicolas Dauby, et al.
Vaccine|August 28, 2019
High rate of rubella seronegativity in perinatally-infected HIV women of childbearing age: A case-control studyAbraham J Beun, Tine Grammens, Marc Hainaut, et al.
Expert Review of Vaccines|March 3, 2022
An instrument to measure psychosocial determinants of health care professionals' vaccination behavior: Validation of the Pro-VC-Be questionnairePierre Verger, Lisa Fressard, Anna Soveri, et al.
Journal of Leukocyte Biology|December 10, 2021
Differential expression of maturation and activation markers on NK cells in patients with active and latent tuberculosisNurhan Albayrak, Violette Dirix, Laetitia Aerts, et al.
AIDS (London, England)|February 25, 2022
Durability of tetanus seroprotection in people living with HIVNicolas Dauby, Cathy Gobert, Asma Benslimane, et al.
Case Reports in Ophthalmological Medicine|February 25, 2021
Multimodal Imaging in AIDS-Related Ocular CryptococcosisMaria Fernanda Flores Herrera, Nicolas Dauby, Evelyne Maillart, et al.
Plos Neglected Tropical Diseases|December 31, 2009
Maternal infection with Trypanosoma cruzi and congenital Chagas disease induce a trend to a type 1 polarization of infant immune responses to vaccinesNicolas Dauby, Cristina Alonso-Vega, Eduardo Suarez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 13, 2025
Immunogenicity and safety of two versus three doses of 9-valent vaccine against Human papillomavirus (HPV) in women with HIV: the Papillon randomized trialDeborah Konopnicki, Christine Gilles, Yannick Manigart, et al.
Pageof 11